5th APV Continuous Manufacturing Conference | CN 6965
Venue
Scandic MölndalBarnhemsgatan 23
431 31 Mölndal
Committee
■■ Giustino di Pretoro, Janssen, Research&Development, Belgium
■■ Dejan Djuric, Bayer, Germany
■■ Geert Verreck, Janssen Research&Development, Belgium
■■ Peter Kleinebudde, Heinrich–Heine-University Düsseldorf, Germany
■■ Victoria Pauli, Novartis, Switzerland
Call for papers
The abstract should be prepared using Microsoft Word as one A4 page typed in Times New Roman, font size 12.
Deadline for abstract submission:
15 March 2024
Please submit your abstracts by e-mail to Martin Bornhöft mb@apv-mainz.de.
You will be notified of acceptance of your paper by 20 March 2024.
Description
Take your chance on early bird registration fees until 28 February 2024!
Take your chance on the facility tour at AstraZeneca on 25 April 2024 by speedy registration!
Only 60 places for the facility tour available!
Kindly supported by AstraZeneca R&D
Kindly sponsored by IMA Actice
Target groups
People working in formulation & process development, engineering, quality, commercial manufacturing, academia and authorities.
Objective
Key sessions on
■■ Real-time release approach
■■ Validation of CM lines
■■ Continuous blending performance
■■ Green CM
■■ Modular design and end to end manufacturing in a single room
■■ PAT tools for CM
■■ Containment and CM
Cooperation partner(s)
AstraZeneca R&D
AstraZeneca has provided a sponsorship grant towards this independent Programme.
Registration fee
| 28.02.2024 | 29.02.2024 | |
|---|---|---|
| Industry | 1,590.00 € | 1,690.00 € |
| Authority/University | 795.00 € | 845.00 € |
| Full time students | 230.00 € | 270.00 € |
Organizer(s)
APV-Office
Dr. Martin Bornhöft
Phone: +49 6131 9769-0
Fax: +49 6131 9769-69
E-mail: apv@apv-mainz.de
www: https://www.apv-mainz.de/